Provenance Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59K | Hold |
150
| – | – | ﹤0.01% | 359 |
|
|
2025
Q1 | $3.73K | Hold |
150
| – | – | ﹤0.01% | 367 |
|
|
2024
Q4 | $2.83K | Hold |
150
| – | – | ﹤0.01% | 401 |
|
|
2024
Q3 | $2.26K | Hold |
150
| – | – | ﹤0.01% | 449 |
|
|
2024
Q2 | $4.29K | Hold |
150
| – | – | ﹤0.01% | 331 |
|
|
2024
Q1 | $4.38K | Hold |
150
| – | – | ﹤0.01% | 360 |
|
|
2023
Q4 | $5.06K | Hold |
150
| – | – | ﹤0.01% | 362 |
|
|
2023
Q3 | $4.6K | Buy |
+150
| New | +$4.6K | ﹤0.01% | 275 |
|